boston scientif corp engag develop
manufactur market medic devic
use broad rang intervent medic
specialti compani product technolog
use diagnos treat wide rang medic
vascular urolog women health chronic pain
condit compani headquart natick
reason report
price chang estim chang analysi
report complet oper result importantli
organ revenu growth forecast acceler strong
expans prior inclus pend btg acquisit
still forecast billion cash use pursu
tuck-in despit plan reduc corpor indebted
chang estim fine tune former
addit moder former revenu estim
guidanc summari establish revenu guidanc
rang billion billion pre-cal consensu
per share pre-cal consensu assum
headwind approxim million million
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
adopt peripher intervent revenu million increas report driven launch
debt follow month bring compani leverag ratio ebitda end
reserveandispayableoversevenyear evenwiththeplanneddebtreductionandpaymenttowardsthetaxli
million except per share data
research develop
sale market administr
incom prior tax
million except per share data
compani document stephen inc estim
becton dickinson compani
data reflect stephen estim other consensu
stephen inc estim
compani document
fiscal period
fiscal period
fiscal period
consolid statement incom
million except per share data
good sold
research develop
sale market administr
incom prior tax
weight averag share issu outstand
compani report stephen inc estim
compani mention page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
